𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Investigation of leucine-rich repeat kinase 2 : Enzymological properties and novel assays

✍ Scribed by Vasanti S. Anand; Laurie J. Reichling; Kerri Lipinski; Wayne Stochaj; Weili Duan; Kerry Kelleher; Pooja Pungaliya; Eugene L. Brown; Peter H. Reinhart; Richard Somberg; Warren D. Hirst; Steven M. Riddle; Steven P. Braithwaite


Book ID
111312746
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
539 KB
Volume
276
Category
Article
ISSN
1432-1327

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Clinical and pathological characteristic
✍ Jason P. Covy; Wuxing Yuan; Elisa A. Waxman; Howard I. Hurtig; Vivianna M. Van D πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 256 KB

## Abstract Mutations in LRRK2 are the single most common known cause of Parkinson's disease (PD). Two new PD patients with LRRK2 mutation were identified from a cohort with extensive postmortem assessment. One of these patients harbors the R793M mutation and presented with the typical clinical and

The Roc domain of leucine-rich repeat ki
✍ Payal N. Gandhi; Xinglong Wang; Xiongwei Zhu; Shu G. Chen; Amy L. Wilson-Delfoss πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 399 KB

## Abstract Mutations in the __leucine‐rich repeat kinase 2__ (__LRRK2__) gene are the leading cause of genetically inherited Parkinson's disease (PD). Although this multidomain protein has been shown to have both GTPase and kinase activities through the Roc and MAPKKK domains, respectively, the pr